In the realm of functional medicine and diagnostic testing, identifying reliable biomarkers is essential for understanding physiological states and guiding personalized health strategies. 3,5-Dihydroxybenzoic Acid, known by its CAS number 99-10-5 and also referred to as alpha-Resorcylic Acid, has emerged as a significant metabolite with implications for dietary habits and gut microbiome status.

Research indicates a strong correlation between the levels of 3,5-Dihydroxybenzoic Acid in urine and plasma and the consumption of whole-grain foods, particularly wheat and rye. It is a primary metabolite of alkylresorcinols, which are phenolic lipids found abundantly in the outer layers and bran of these cereal grains. This connection makes 3,5-Dihydroxybenzoic Acid a valuable biomarker for assessing whole-grain intake. For healthcare providers and researchers interested in dietary assessments and gut health, understanding this relationship is key.

Furthermore, the presence of 3,5-Dihydroxybenzoic Acid can be influenced by microbial activity in the gastrointestinal tract, suggesting its potential use as an indicator of microbiome status. Elevated levels might point towards dysbiosis, a condition characterized by an imbalance in the gut flora. This opens avenues for its inclusion in comprehensive metabolic and organic acid profiling tests. Professionals seeking to buy high-purity 3,5-Dihydroxybenzoic Acid for laboratory analysis or research purposes can source it from reliable suppliers like NINGBO INNO PHARMCHEM.

At NINGBO INNO PHARMCHEM, we supply high-quality 3,5-Dihydroxybenzoic Acid that can be utilized in diagnostic laboratories and research settings. We are committed to providing materials that support accurate and insightful health assessments. If you are a laboratory manager or researcher looking to purchase CAS 99-10-5, we encourage you to contact us for product specifications, pricing, and sample availability. Partnering with a reputable manufacturer ensures the integrity of your diagnostic testing and research findings.